These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37271035)

  • 1. Cardiomyopathy-associated variants alter the structure and function of the α-actinin-2 actin-binding domain.
    Atang AE; Rebbeck RT; Thomas DD; Avery AW
    Biochem Biophys Res Commun; 2023 Aug; 670():12-18. PubMed ID: 37271035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy mutations in the calponin-homology domain of ACTN2 affect actin binding and cardiomyocyte Z-disc incorporation.
    Haywood NJ; Wolny M; Rogers B; Trinh CH; Shuping Y; Edwards TA; Peckham M
    Biochem J; 2016 Aug; 473(16):2485-93. PubMed ID: 27287556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis.
    Mohapatra B; Jimenez S; Lin JH; Bowles KR; Coveler KJ; Marx JG; Chrisco MA; Murphy RT; Lurie PR; Schwartz RJ; Elliott PM; Vatta M; McKenna W; Towbin JA; Bowles NE
    Mol Genet Metab; 2003; 80(1-2):207-15. PubMed ID: 14567970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertrophic cardiomyopathy-linked variants of cardiac myosin-binding protein C3 display altered molecular properties and actin interaction.
    Da'as SI; Fakhro K; Thanassoulas A; Krishnamoorthy N; Saleh A; Calver BL; Safieh-Garabedian B; Toft E; Nounesis G; Lai FA; Nomikos M
    Biochem J; 2018 Dec; 475(24):3933-3948. PubMed ID: 30446606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional studies of yeast actin mutants corresponding to human cardiomyopathy mutations.
    Wong WW; Doyle TC; Cheung P; Olson TM; Reisler E
    J Muscle Res Cell Motil; 2001; 22(8):665-74. PubMed ID: 12222827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actin mutations in hypertrophic and dilated cardiomyopathy cause inefficient protein folding and perturbed filament formation.
    Vang S; Corydon TJ; Børglum AD; Scott MD; Frydman J; Mogensen J; Gregersen N; Bross P
    FEBS J; 2005 Apr; 272(8):2037-49. PubMed ID: 15819894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mono- and Biallelic Protein-Truncating Variants in Alpha-Actinin 2 Cause Cardiomyopathy Through Distinct Mechanisms.
    Lindholm ME; Jimenez-Morales D; Zhu H; Seo K; Amar D; Zhao C; Raja A; Madhvani R; Abramowitz S; Espenel C; Sutton S; Caleshu C; Berry GJ; Motonaga KS; Dunn K; Platt J; Ashley EA; Wheeler MT
    Circ Genom Precis Med; 2021 Dec; 14(6):e003419. PubMed ID: 34802252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease modeling of a mutation in α-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy.
    Prondzynski M; Lemoine MD; Zech AT; Horváth A; Di Mauro V; Koivumäki JT; Kresin N; Busch J; Krause T; Krämer E; Schlossarek S; Spohn M; Friedrich FW; Münch J; Laufer SD; Redwood C; Volk AE; Hansen A; Mearini G; Catalucci D; Meyer C; Christ T; Patten M; Eschenhagen T; Carrier L
    EMBO Mol Med; 2019 Dec; 11(12):e11115. PubMed ID: 31680489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 10 genes encoding cardiac proteins in Doberman Pinschers with dilated cardiomyopathy.
    O'Sullivan ML; O'Grady MR; Pyle WG; Dawson JF
    Am J Vet Res; 2011 Jul; 72(7):932-9. PubMed ID: 21728854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant and benign mutations in familial cardiomyopathies: insights into mutations linked to complex cardiovascular phenotypes.
    Xu Q; Dewey S; Nguyen S; Gomes AV
    J Mol Cell Cardiol; 2010 May; 48(5):899-909. PubMed ID: 20298698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for clinical heterogeneity in inherited cardiomyopathies due to myopalladin mutations.
    Purevjav E; Arimura T; Augustin S; Huby AC; Takagi K; Nunoda S; Kearney DL; Taylor MD; Terasaki F; Bos JM; Ommen SR; Shibata H; Takahashi M; Itoh-Satoh M; McKenna WJ; Murphy RT; Labeit S; Yamanaka Y; Machida N; Park JE; Alexander PM; Weintraub RG; Kitaura Y; Ackerman MJ; Kimura A; Towbin JA
    Hum Mol Genet; 2012 May; 21(9):2039-53. PubMed ID: 22286171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium.
    Bermúdez-Jiménez FJ; Carriel V; Santos-Mateo JJ; Fernández A; García-Hernández S; Ramos KA; Piqueras-Flores J; Cabrera-Romero E; Barriales-Villa R; de la Higuera Romero L; Alcalá López JE; Gimeno Blanes JR; Sánchez-Porras D; Campos F; Alaminos M; Oyonarte-Ramírez JM; Álvarez M; Tercedor L; Brodehl A; Jiménez-Jáimez J
    Rev Esp Cardiol (Engl Ed); 2023 May; 76(5):301-311. PubMed ID: 35952944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel α-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study.
    Girolami F; Iascone M; Tomberli B; Bardi S; Benelli M; Marseglia G; Pescucci C; Pezzoli L; Sana ME; Basso C; Marziliano N; Merlini PA; Fornaro A; Cecchi F; Torricelli F; Olivotto I
    Circ Cardiovasc Genet; 2014 Dec; 7(6):741-50. PubMed ID: 25173926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular autopsy and clinical family screening in a case of sudden cardiac death reveals ACTN2 mutation related to hypertrophic/dilated cardiomyopathy and a novel LZTR1 variant associated with Noonan syndrome.
    Kraoua L; Jaouadi H; Allouche M; Achour A; Kaouther H; Ahmed HB; Chaker L; Maazoul F; Ouarda F; Zaffran S; M'rad R
    Mol Genet Genomic Med; 2022 Jul; 10(7):e1954. PubMed ID: 35656879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy.
    Rodriguez G; Ueyama T; Ogata T; Czernuszewicz G; Tan Y; Dorn GW; Bogaev R; Amano K; Oh H; Matsubara H; Willerson JT; Marian AJ
    Circ Cardiovasc Genet; 2011 Aug; 4(4):349-58. PubMed ID: 21642240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy.
    Matsumoto Y; Hayashi T; Inagaki N; Takahashi M; Hiroi S; Nakamura T; Arimura T; Nakamura K; Ashizawa N; Yasunami M; Ohe T; Yano K; Kimura A
    J Muscle Res Cell Motil; 2005; 26(6-8):367-74. PubMed ID: 16465475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy.
    Geier C; Perrot A; Ozcelik C; Binner P; Counsell D; Hoffmann K; Pilz B; Martiniak Y; Gehmlich K; van der Ven PF; Fürst DO; Vornwald A; von Hodenberg E; Nürnberg P; Scheffold T; Dietz R; Osterziel KJ
    Circulation; 2003 Mar; 107(10):1390-5. PubMed ID: 12642359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
    Al-Shafai KN; Al-Hashemi M; Manickam C; Musa R; Selvaraj S; Syed N; Vempalli F; Ali M; Yacoub M; Estivill X
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1709. PubMed ID: 34137518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms in cardiomyopathy.
    Dadson K; Hauck L; Billia F
    Clin Sci (Lond); 2017 Jul; 131(13):1375-1392. PubMed ID: 28645928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered interactions between cardiac myosin binding protein-C and α-cardiac actin variants associated with cardiomyopathies.
    Chow ML; Shaffer JF; Harris SP; Dawson JF
    Arch Biochem Biophys; 2014 May; 550-551():28-32. PubMed ID: 24736382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.